To the best of our knowledge, this is the first report to showing changes in three key parameters as NF-κB, oxLDL, and LOX-1 in systemic oxidative stress using an analysis of multiple biomarkers in COVID-19 patients. This evidence concerns the gene NFKB1 and COVID-19.